2026年2月5日，轩竹生物科技股份有限公司（港交所股票代码：02575）发布2026年1月股份变动月报，披露截至1月31日的股本情况。公告显示，该公司注册股本仍包括160,701,996股H股及357,245,794股未上市股份，总计517,947,790股，与上期保持一致。
报告期内未发生新增发行、购回或注销，H股及未上市股份数量无变化，公共持股量维持上市规则要求的24.96%。同时，公告未披露任何股份期权、可换股票据及其他股权激励计划的变动信息。
截至2026年1月31日，轩竹生物股本维持稳定。公司确认遵守香港联交所相关上市规则及法律规定，公告由联席公司秘书何成明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.